Page last updated: 2024-08-24

xanthoxyline and ruthenium

xanthoxyline has been researched along with ruthenium in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bezerra, DP; Carlos, RM; de Carvalho, NC; Dias, RB; Dos Santos, ER; Neves, SP; Nogueira, PCL; Oliveira, RMM; Rocha, CAG; Sales, CBS; Soares, MBP; Valverde, LF	1

Other Studies

1 other study(ies) available for xanthoxyline and ruthenium

Article	Year
A novel ruthenium complex with xanthoxylin induces S-phase arrest and causes ERK1/2-mediated apoptosis in HepG2 cells through a p53-independent pathway. Cell death & disease, 2018, 01-23, Volume: 9, Issue:2 Topics: Acetophenones; Animals; Antineoplastic Agents; Apoptosis; Caspase Inhibitors; Caspases; Cell Cycle Checkpoints; DNA; Female; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Intercalating Agents; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Mice, SCID; Models, Biological; Protein Kinase Inhibitors; Proton Magnetic Resonance Spectroscopy; Ruthenium; S Phase; Spheroids, Cellular; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays	2018

Article

Year

A novel ruthenium complex with xanthoxylin induces S-phase arrest and causes ERK1/2-mediated apoptosis in HepG2 cells through a p53-independent pathway.

Cell death & disease, 2018, 01-23, Volume: 9, Issue:2

Topics: Acetophenones; Animals; Antineoplastic Agents; Apoptosis; Caspase Inhibitors; Caspases; Cell Cycle Checkpoints; DNA; Female; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Intercalating Agents; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Mice, SCID; Models, Biological; Protein Kinase Inhibitors; Proton Magnetic Resonance Spectroscopy; Ruthenium; S Phase; Spheroids, Cellular; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2018